| Poly (ADP-Ribose) polymerase inhibitors: talazoparib in ovarian cancer and beyond S Boussios, C Abson, M Moschetta, E Rassy, A Karathanasi, T Bhat, ... Drugs in R&D 20, 55-73, 2020 | 123 | 2020 |
| BRCA mutations in ovarian and prostate cancer: bench to bedside S Boussios, E Rassy, M Moschetta, A Ghose, S Adeleke, E Sanchez, ... Cancers 14 (16), 3888, 2022 | 101 | 2022 |
| Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach S Boussios, P Karihtala, M Moschetta, C Abson, A Karathanasi, ... Investigational new drugs 38, 181-193, 2020 | 89 | 2020 |
| Recent insights into PARP and immuno-checkpoint inhibitors in epithelial ovarian cancer A Revythis, A Limbu, C Mikropoulos, A Ghose, E Sanchez, M Sheriff, ... International journal of environmental research and public health 19 (14), 8577, 2022 | 84 | 2022 |
| Epithelial ovarian cancer: providing evidence of predisposition genes S Shah, A Cheung, M Kutka, M Sheriff, S Boussios International Journal of Environmental Research and Public Health 19 (13), 8113, 2022 | 83 | 2022 |
| Non-epithelial ovarian cancers: how much do we really know? A Cheung, S Shah, J Parker, P Soor, A Limbu, M Sheriff, S Boussios International journal of environmental research and public health 19 (3), 1106, 2022 | 79 | 2022 |
| Angiogenesis and anti-angiogenic treatment in prostate cancer: mechanisms of action and molecular targets E Ioannidou, M Moschetta, S Shah, JS Parker, MA Ozturk, ... International journal of molecular sciences 22 (18), 9926, 2021 | 73 | 2021 |
| Unraveling the wide spectrum of melanoma biomarkers A Revythis, S Shah, M Kutka, M Moschetta, MA Ozturk, G Pappas-Gogos, ... Diagnostics 11 (8), 1341, 2021 | 71 | 2021 |
| Wise management of ovarian cancer: on the cutting edge S Boussios, C Mikropoulos, E Samartzis, P Karihtala, M Moschetta, ... Journal of personalized medicine 10 (2), 41, 2020 | 65 | 2020 |
| Melanoma of unknown primary: New perspectives for an old story S Boussios, E Rassy, E Samartzis, M Moschetta, M Sheriff, ... Critical reviews in oncology/hematology 158, 103208, 2021 | 64 | 2021 |
| Advances in ovarian cancer treatment beyond PARP inhibitors F Aliyuda, M Moschetta, A Ghose, K Sofia Rallis, M Sheriff, E Sanchez, ... Current Cancer Drug Targets 23 (6), 433-446, 2023 | 63 | 2023 |
| Genetic aberrations of DNA repair pathways in prostate cancer: translation to the clinic A Ghose, M Moschetta, G Pappas-Gogos, M Sheriff, S Boussios International Journal of Molecular Sciences 22 (18), 9783, 2021 | 55 | 2021 |
| Aberrations of DNA repair pathways in prostate cancer: A cornerstone of precision oncology S Boussios, E Rassy, S Shah, E Ioannidou, M Sheriff, N Pavlidis Expert opinion on therapeutic targets 25 (5), 329-333, 2021 | 53 | 2021 |
| Primary Thyroid‐Like Follicular Renal Cell Carcinoma: An Emerging Entity S Malde, I Sheikh, I Woodman, D Fish, P Bilagi, MKM Sheriff Case reports in Pathology 2013 (1), 687427, 2013 | 30 | 2013 |
| Development of new poly (ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis? S Boussios, M Moschetta, P Karihtala, EP Samartzis, M Sheriff, ... Annals of translational medicine 8 (24), 2020 | 25 | 2020 |
| Renal cell cancer–insights in drug resistance mechanisms H Aweys, D Lewis, M Sheriff, RD Rabbani, P Lapitan, E Sanchez, ... Anticancer Research 43 (11), 4781-4792, 2023 | 20 | 2023 |
| Management of metastatic spinal cord compression in secondary care: a practice reflection from Medway Maritime Hospital, Kent, UK S Shah, M Kutka, K Lees, C Abson, M Hadaki, D Cooke, C Neill, M Sheriff, ... Journal of Personalized Medicine 11 (2), 110, 2021 | 17 | 2021 |
| Hallmarks of the tumour microenvironment of gliomas and its interaction with emerging immunotherapy modalities CA Linares, A Varghese, A Ghose, SD Shinde, S Adeleke, E Sanchez, ... International Journal of Molecular Sciences 24 (17), 13215, 2023 | 15 | 2023 |
| Solitary renal fossa recurrence of renal cell carcinoma after nephrectomy JJ Chow, K Ahmed, Z Fazili, M Sheikh, M Sheriff Reviews in Urology 16 (2), 76, 2014 | 10 | 2014 |
| Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities S Boussios, M Sheriff, E Rassy, M Moschetta, EP Samartzis, R Hallit, ... Annals of Translational Medicine 9 (5), 2021 | 8 | 2021 |
